Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
Clinical trial NCT00448214 · COMPLETED
Trial details
- NCT number
- NCT00448214
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2008-10-01
- Enrollment
- 448
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.